Read More Healthcare Industry News Tracer Biotechnologies and Qiagen (NYSE: QGEN) forge oncology alliance to expand MRD testing Qiagen partners with Tracer Biotechnologies to advance solid tumor MRD testing via QIAcuity. See how this impacts QGEN stock and oncology diagnostics. byPallavi MadhirajuJune 6, 2025